OBs-mucTivF jaundice is amenable to surgical treatment when the obstruction is extrahepatic. In recent years it has been recognised that the obstruction may be intrahepatic and the complete picture of obstructive jaundice may be seen without obstruction of the main bile ducts. It is important to differentiate between intrahepatic anid extrahepatic cholestasis in order to avoid unnecessary surgical interference. In differential diagnosis liver function tests are valuable. Liver biopsy, which can be conveniently done with a Menghini liver biopsy needle, may be diagnostic.
In view of the diagnostic difficultv a report of a case of intrahepatic cholestasis might be of interest. The significance of liver function tests and the multiple atiology of intrahepatic cholestasis are discussed.
CASE REPORT. The patient was a woman aged 71 years. She was admitted to hospital on 29th March, 1962 . She gave a history of painless jaundice of six weeks' duration, and she had troublesome pruritus. She had noticed the urine to be dark and the stools pale. There was no history of recent drug administration. Apart In the intestine bilirubin undcrgocs reduction by bacterial action. The main product is urobilinogen which is partially re-oxidised to urobilin. Sim1all am0ouIts of urobilin and urobilinogen are re-absorbed from the intestine and most of this is re-excreted by the liver after re-oxidation to bilirubin. The very small amount of absorbed urobilinogen not re-excreted by the norimial liver passes into the systemic blood stream and is excreted in the urinc. This amount does not give the usual qualitative test for urobilinogen.
Hyperbilirubininiia can be produced in three ways: -(1) By obstruction to the outflow of bile; the pigment in the plasma is chiefly conjugated bilirubin.
(2) By excessive production of bilirubin-as in hxmolytic jaunidice; the pigment in the plasma is chiefly free bilirubin. The normal liver has a great capacitxy to conjugate bilirubin, the amount excreted increasing in proportion to the square of the concentration in the plasma. (3) By inability of damaged liver cells to transmit even the normal amounts of bilirubin as in the clinical "toxic" and "infective" types of jaundice. Hepatogenous jaundice is usually associated with some degree of obstruction to the bile flow and both frec and conjugated bilirubin appear in the plasma. The van den Bergh measures the concentration of bilirubin in the plasma. Normally the concentrationi is between 0.1 and 0.8 mg. per 100 ml. of serum. The van den Bergh is of doubtful value in differential diagniosis of jaundice, but it is useful as a quantitative measure and is valuable in assessing progress of the case.
Bilirubinuria occurs when serum conjugated bilirubin exceeds 2 mg. per 100 ml. Urobilinogen occurs in the urine in conditions associated with excessive pro-duction and excretion of bilirubin. One of the most difficult functions of the hepatic cells is the re-oxidation of urobilinogen to bilirubin. One of the earliest signs of hepatic cellular damage is excessive excretion of urobilinogen in the urine. Urobilinogen may be detected in the urine in cases of infective hepatitis before the development of overt jaundice.
Serum alkaline phosphatase levels usually parallel the obstructive factor of jaundice. The King and Armstrong method measures the liberation of phenol from phenyl phosphate with fifteen minutes' incubation at 370 C. and with the pH adjusted to 10.0. A plasma alkaline phosphatase greater than 35 K.A. units per 100 ml. strongly suggests obstructive jaundice; a figure belowv 25 units per 100 ml. suggests hepatogenous jaundice. A clear differentiation is not always possible because many cases give intermediate values.
The cholesterol of the plasma is usually increased above the normal of 240 mg. per 100 ml. in cases of obstructive jaundice.
Many tests not based directly on the production and excretion of bile constituents are of value in differential diagnosis of jaundice. In hepatogenous jaundice tests based oni the metabolic functions show a greater abnormality than those based on excretory funlctions. In obstructive jaundice the excretory functions are more inmpaired.
Electrophoretic estiimiationl of the plasma proteins is one of the most valuable of the nmetabolic liver funictioni tests. The liver is an important organ in the synthesis of plasma proteins. Ilflammnatory and degenerative lesions of the liver are manifested by chaniges in the plasma proteins, viz., a decrease in the albumin anid an increase in the gammna globulin. Failure of synthesis accounts for the hypoalbuminxnmia. The cause of the inicreased gamma globulin is obscure. In obstructive jaundice there may be a rise in the beta globulin which reflects the raised plasma cholesterol.
Changes in the plasnma proteins are the basis of the flocculation tests. The behaviour of a colloidal solutioni of several proteins towards precipitating agents depends upon the relative concentrations of the different proteins. The cephalin cholesterol and thymol turbidity reflect changes in the plasma proteins. The flocculation tests are normal in obstructive jaundice and are usually positive in hepatogenous jaundice.
Estimation of certain enlzymes are of value in differential diagnosis. Serum transaminases can be assayed by their activity in transferring an amino group from glutamic acid to oxalacetic acid (SGOT) and from glutamic acid to pyruvic acid (SGPT A block of the bile duct mav be shown by the technique of percutaneous transhepatic cholangiography. In patients with extrahepatic cholestasis a bile duct mnay, be punctured. The procedure carries a risk of biliary peritonitis and is not recommended.
INTRAHF,PATTC CHOLESTASTS.
The mechanism of jaundice in intrahepatic cholestasis is doubtful. Electron microscopy has showin distortion of the microvilli lining the bile canaliculi. An additional factor may be a disturbance of intracellular bilirubin transport from the hepatic cell into the bile canaliculus. As a consequence, bile accumulates in the intralobular bile canaliculi. Obstruction of the bile ductules bv infiltrates in the portal zones is unlikely to be a factor.
One important cause of intrahepatic cholestasis is the hepatotoxicity of drugs. Certain drugs, including choloroform, carbon tetrachloride, tetrachlorethylene, ethyl chloride, benzene derivatives, certain metallic poisons, iproniazid and other hydrazine monoamine-oxidase inhibitors, isonicotinic acid, and pyrazinamide are direct hepato-cellular poisons which produce centrizonal liver necrosis. This state is reflected by high serum transaminase levels and abnormal plasma protein pattern. Hepatic damage is often associated with acute renal tubular necrosis.
In contrast to this severe hepatocellular jaundice due to drugs is the more benignl intrahepatic drug cholestasis which is manifested by painless, afebrile, obstructive jaundice. The liver is not enlarged andc not tender. Liver biopsv may be equivocal and such cases may come to laparotomy wvhich reveals the main bile ducts to be patent.
There are two types of cholestatic drug jaundice. The first type is caused by a hypersensitivity reaction and may follow administration of chlorpromazine ("largactil") and other phenothiazine derivatives such as promazine ("sparine") aind trifluperazine ("stelazine"), para-aminosalicyclic acid, thiouracil, chlorpropamide ("diabinese"), and nitrofurantoin ("furadantin"). Cholestatic jaundice develops in about I per cent. of patients taking chlorpromazine. Jaundice may follow a single dose or one day's treatment. The initial manifestations may be leucopenia, eosinophilia, drug fever, and drug rash. Recovery usuallv takes place within one to four weeks after the drug has been discontinued. Occasionally jaundice is much more prolonged and the clinical picture in such cases simulates primary biliarv cirrhosis. The serum cholesterol and alkaline phosphatase levels are high from the outset.
The second type of acute intrahepatic drug cholestasis may complicate treatment with methvltestosterone and other related steroids, including nore-29 thandrolone ("nilevar") and methandienone ("dianobol") . This type is not due to hypersensitivity but is a straightforward consequence of dosage and duration of administration. The clinical picture of steroidal jaundice resembles that seen in chlorpromazine jaundice. Liver biopsy reveals inspissation of bile in the canaliculi but there is no portal-zone cellular reaction as occurs with chlorpromazine jaundice.
Another cause of intrahepatic obstructive jaundice is virus hepatitis. Jaundice persists for several months and recovery is complete. This is in contrast to subacute hepatitis and cirrhosis which may complicate an attack of virus hepatitis and is conditioned bv methionine deficiency. The atypical hepatitis with intrahepatic cholestasis is the variety which has been called cholangiolitic hepatitis. According to Dubin the xtiological agent is a variant of the virus of infective hepatitis. In cholangiolitic hepatitis there is no biochemical evidence of hepatocellular damage. The serum transaminase and the plasma protein pattern are normal; the serum alkaline phosphatase is usually slightly raised. The patient, in whom intrahepatic cholestasis is due to cholangiolitic hepatitis, sometimes shows a dramatic response to corticosteroid therapy. Prednisolone, 40 mg. daily for four days, may cause a fall in the serum bilirubin level. The action of cortiscosteroid in alleviating the jaundice is obscure.
A rare type of intrahepatic cholestasis occurs during pregnancy. Primarv biliarv cirrhosis is another type of intrahepatic cholestasis of obscure mechanism. The onset is insidious anid liver biopsy shows mlarked infiltratioll in the portal zones.
SUMMARY.
The difficulty in diagnosis of intrahepatic obstructive jaundice may lead to unnecessary surgical intervention because an incorrect diagnosis of extrahepatic obtruction is made.
It is essential to elicit anv history of recent drug administration. Fever, rigors, and leucocytosis indicate extrahepatic obstruction and reflect secondarv infection in the dilated ducts.
Liver biopsy mav be diagnostic but it is sometimes difficult to distiniguisl between intrahepatic and extrahepatic cholestasis.
Response to a trial of corticosteroid therapy would indicate intrahepatic obstruction.
In doubtful cases serial liver function tests should be performed at weekly intervals during a period of three to four weeks' observation.
Sonie patients may require laparotomv to establish a definitive diagnosis.
We are indebted to Dr. J. E. Morison for his report on the liver biopsy and to Dr. R. A. Ncely for help and co-operation with the biochemical investigations.
